Increased cardiac weight in interleukin-6 transgenic mice with viral infection accompanies impaired expression of natriuretic peptide genes

Research Communications in Molecular Pathology and Pharmacology

Volumn 110, Issue 5-6, 2001, Pages 275-283

  Tanaka, Toru ^a   Kanda, Tsugiyasu ^b   Itoh, Toru ^b   Tsugawa, Hiroichi ^b   Takekoshi, Noboru ^b   Yamakawa, Jun'ichi ^b   Kurimoto, Masashi ^c   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 6; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; INOCULATION; MOUSE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BODY WEIGHT; CARDIOMEGALY; DNA PROBES; ENCEPHALOMYOCARDITIS VIRUS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; RATS;

EID: 0042808779     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF (2000). Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med. 6:583-588.
2. Bhat GJ, Baker KM (1998). Cross-talk between angiotensin II and interleukin-6-induced signaling through Stat3 transcription factor. Basic Res Cardiol. 93 Suppl 3:26-29.
3. Blum A, Miller H (2001). Pathophysiological role of cytokines in congestive heart failure. Annu Rev med 2001, 52, 15-27.
4. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML (1990). Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70:665-667.
5. Chusho H, Ogawa Y, Tamura N, Suda M, Yasoda A, Miyazawa T, Kishimoto I, Komatsu Y, Itoh H, Tanaka K, Saito Y, Garbers DL, Nakao K (2001). Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology 141:3807-3813
6. Durocher D, Grepin C, Nemer M (1998). Regulation of gene expression in the endocrine heart. Recent Prog Horm Res. 53:7-23.
7. de Boer RA, Henning RH, Suurmeijer AJ, Pinto YM, Olthof E, Kirkels JH, van Gilst WH, Crijns HJ, van Veldhuisen DJ (2001).Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease. Int J Cardiol 78:5-12
8. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH (1996). Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 78:954-961.
9. Grin, C., Dagnino, L., Robitaille, L., Haberstroh, L., Antakly, T., and Nemer, M (1994). A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol. Cell. Biol. 14:3115-3129
10. Hirota H, Yoshida K, Kishimoto T, Taga T (1995). Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 92:4862-4866
11. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr., Muller W, Chien KR (1999). Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189-198.
12. Inoue M, Kanda T, Arai M, Suga T, Suzuki T, Kobayashi I, Nagai R (1998). Impaired expression of brain natriuretic peptide gene in diabetic rats with myocardial infarction. Exp Clin Endocrinol Diabetes. 106:484-488.
13. Kanda T, Yokoyama T, Imai S, Suzuki T, Murata K, Kobayashi I (1995). Effect of combination therapy with OK432 and recombinant human interferon-alpha A/D on atrial natriuretic peptide gene expression in mice with viral myocarditis. J Pharmacol Exp Ther. 274:494-498.
14. Kanda T, McManus JE, Nagai R, Imai S, Suzuki T, Yang D, McManus BM, Kobayashi I (1996). Modification of viral myocarditis in mice by interleukin-6. Circ Res. 78(5):848-56.
15. Kaneko K, Kanda T, Yokoyama T, Nakazato Y, Iwasaki T, Kobayashi I, Nagai R (1997). Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol. 97:3-12.
16. Knowlton KU, Rockman HA, Itani M, Vovan A, Seidman CE, Chien KR (1995). Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest. 96:1311-1318.
17. Komatsu Y, Itoh H, Suga S, Ogawa Y, Hama N, Kishimoto I, Nakagawa O, Igaki T, Doi K, Yoshimasa T, Nakao K (1996). Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res. 78:606-614.
18. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 322:1561-1566.
19. Luchner, A, Stevens TL, Borgeson DD, Redfield MM, Wei C-M, Porter JG, and Burnett JC, Jr (1998). Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol Heart Circ Physiol 274:H1683-H1689.
20. Masciotra S, Picard S, Deschepper CF (1999). Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ Res. 84(12):1453-8.
21. Needleman P, Greenwald JE (1986). Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. N Engl J Med. 314:828-824
22. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, Saito Y, Suga S, Jougasaki M, Imura H (1991). Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 69:491-500.
23. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S (2000). Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 275:29717-29723.
24. Silberbach M, Gorenc T, Hershberger RE, Stork PJ, Steyger PS, Roberts CT Jr (1999). Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem. 274:24858-4864.
25. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vemallis AB, Heath JK, Pennica D, Wood WI, Chien KR (1996). Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 271:9535-9545.